3237-50-1,MFCD00038076
Catalog No.:AA00CK2L

3237-50-1 | 5,5-Dihydroxypyrimidine-2,4,6(1H,3H,5H)-trione

Pack Size
Purity
Availability
Price(USD)
Quantity
  
50mg
95%
3 weeks  
$238.00   $167.00
- +
100mg
95%
3 weeks  
$329.00   $230.00
- +
250mg
95%
3 weeks  
$443.00   $310.00
- +
500mg
95%
3 weeks  
$784.00   $549.00
- +
1g
95%
3 weeks  
$1,000.00   $700.00
- +
2.5g
95%
3 weeks  
$1,904.00   $1,333.00
- +
5g
95%
3 weeks  
$2,790.00   $1,953.00
- +
10g
95%
3 weeks  
$4,109.00   $2,877.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00CK2L
Chemical Name:
5,5-Dihydroxypyrimidine-2,4,6(1H,3H,5H)-trione
CAS Number:
3237-50-1
Molecular Formula:
C4H4N2O5
Molecular Weight:
160.0850
MDL Number:
MFCD00038076
SMILES:
O=C1NC(=O)NC(=O)C1(O)O
NSC Number:
221304
Properties
Computed Properties
 
Complexity:
223  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
4  
Isotope Atom Count:
0  
Rotatable Bond Count:
0  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
-2.5  

Literature

Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

Journal: PLoS computational biology 20111201

Title: A predictive ligand-based Bayesian model for human drug-induced liver injury.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20101201

Title: 5,5-Dihydroxy-barbituric acid 1,4-dioxane hemisolvate.

Journal: Acta crystallographica. Section E, Structure reports online 20100501

Title: Uric acid may inhibit glucose-induced insulin secretion via binding to an essential arginine residue in rat pancreatic beta-cells.

Journal: Bioorganic & medicinal chemistry letters 20050215

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 3237-50-1
Tags:3237-50-1 Molecular Formula|3237-50-1 MDL|3237-50-1 SMILES|3237-50-1 5,5-Dihydroxypyrimidine-2,4,6(1H,3H,5H)-trione
Catalog No.: AA00CK2L
3237-50-1,MFCD00038076
3237-50-1 | 5,5-Dihydroxypyrimidine-2,4,6(1H,3H,5H)-trione
Pack Size: 50mg
Purity: 95%
3 weeks
$238.00 $167.00
Pack Size: 100mg
Purity: 95%
3 weeks
$329.00 $230.00
Pack Size: 250mg
Purity: 95%
3 weeks
$443.00 $310.00
Pack Size: 500mg
Purity: 95%
3 weeks
$784.00 $549.00
Pack Size: 1g
Purity: 95%
3 weeks
$1,000.00 $700.00
Pack Size: 2.5g
Purity: 95%
3 weeks
$1,904.00 $1,333.00
Pack Size: 5g
Purity: 95%
3 weeks
$2,790.00 $1,953.00
Pack Size: 10g
Purity: 95%
3 weeks
$4,109.00 $2,877.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00CK2L
Chemical Name: 5,5-Dihydroxypyrimidine-2,4,6(1H,3H,5H)-trione
CAS Number: 3237-50-1
Molecular Formula: C4H4N2O5
Molecular Weight: 160.0850
MDL Number: MFCD00038076
SMILES: O=C1NC(=O)NC(=O)C1(O)O
NSC Number: 221304
Properties
Complexity: 223  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 11  
Hydrogen Bond Acceptor Count: 5  
Hydrogen Bond Donor Count: 4  
Isotope Atom Count: 0  
Rotatable Bond Count: 0  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: -2.5  
Literature fold

Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

Journal: PLoS computational biology20111201

Title: A predictive ligand-based Bayesian model for human drug-induced liver injury.

Journal: Drug metabolism and disposition: the biological fate of chemicals20101201

Title: 5,5-Dihydroxy-barbituric acid 1,4-dioxane hemisolvate.

Journal: Acta crystallographica. Section E, Structure reports online20100501

Title: Uric acid may inhibit glucose-induced insulin secretion via binding to an essential arginine residue in rat pancreatic beta-cells.

Journal: Bioorganic & medicinal chemistry letters20050215

Building Blocks More >
39232-85-4
39232-85-4
2-(7-Methyl-1H-indol-3-yl)ethanol
AA00CKKY | MFCD09926639
351367-77-6
351367-77-6
2-Amino-5-chloro-4-fluorobenzoic acid
AA00CKUV | MFCD09861352
34497-54-6
34497-54-6
3-Hydroxy-2-methylquinolin-4(1h)-one
AA00CL4S | MFCD15144272
398491-64-0
398491-64-0
tert-Butyl 3-amino-6,7-dihydro-1h-pyrazolo[4,3-c]pyridine-5(4h)-carboxylate
AA00CLBS | MFCD12964106
37055-79-1
37055-79-1
2-Methoxy-4-phenylphenol
AA00CLLO | MFCD18314937
395673-46-8
395673-46-8
6-Fluoro-4,4-dimethyl-1,3-dihydroquinolin-2-one
AA00CLR1 | MFCD12913844
33656-63-2
33656-63-2
Ethyl 2-oxo-2-(thiazol-2-yl)acetate
AA00CLXV | MFCD08689464
35144-25-3
35144-25-3
(2-(2-Chloroethyl)phenyl)methanol
AA00CM8K | MFCD11646263
35249-62-8
35249-62-8
3-(2-Bromo-4,5-dimethoxyphenyl)propanenitrile
AA00CMJ4 | MFCD00100650
342639-96-7
342639-96-7
Kribb11
AA00CMW8 | MFCD30182306
Submit
© 2017 AA BLOCKS, INC. All rights reserved.